Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Xanthopoulou

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|March 18, 2014
Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practiceDimitrios Alexopoulos, Ioanna Xanthopoulou
Circulation. Cardiovascular Interventions|February 21, 2013
Letter by Alexopoulos et al regarding article, "pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel: the RESET GENE Trial"Dimitrios Alexopoulos, Ioanna Xanthopoulou
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|February 5, 2011
Coronary stent fracture: how frequent it is? Does it matter?Dimitrios Alexopoulos, Ioanna Xanthopoulou
Current Pharmaceutical Design|June 6, 2016
Oral Antiplatelet Treatment in STEMI: Current Practice and Future ConsiderationsIoanna Xanthopoulou, Dimitrios Alexopoulos
JAMA|March 15, 2012
Clopidogrel dosing based on genotypeDimitrios Alexopoulos, Ioanna Xanthopoulou
Journal of Cardiovascular Pharmacology and Therapeutics|July 12, 2018
Does Ticagrelor Improve Endothelial Function?Athanasios Moulias, Ioanna Xanthopoulou, Dimitrios Alexopoulos
Journal of the American College of Cardiology|December 4, 2014
Frequency of inappropriate and nonrecommended prasugrel prescription: great variationsDimitrios Alexopoulos, Ioanna Xanthopoulou, John Goudevenos
The American Journal of Cardiology|May 6, 2014
Effects of P2Y12 receptor inhibition in patients with ST-segment elevation myocardial infarctionDimitrios Alexopoulos, Ioanna Xanthopoulou, John Goudevenos
JACC. Cardiovascular Interventions|November 26, 2011
Percutaneous coronary interventions following coronary artery bypass graft in-hospital mortality and long-term follow-upGrigorios Tsigkas, Ioanna Xanthopoulou, Dimitrios Alexopoulos
Current Pharmaceutical Design|April 16, 2014
Pleiotropic effects of platelet P2Y12 receptor inhibitors: fact or fiction?Athanasios Moulias, Ioanna Xanthopoulou, Dimitrios Alexopoulos
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|March 18, 2014
Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practiceDimitrios Alexopoulos, Ioanna Xanthopoulou
Circulation. Cardiovascular Interventions|February 21, 2013
Letter by Alexopoulos et al regarding article, "pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel: the RESET GENE Trial"Dimitrios Alexopoulos, Ioanna Xanthopoulou
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|February 5, 2011
Coronary stent fracture: how frequent it is? Does it matter?Dimitrios Alexopoulos, Ioanna Xanthopoulou
Current Pharmaceutical Design|June 6, 2016
Oral Antiplatelet Treatment in STEMI: Current Practice and Future ConsiderationsIoanna Xanthopoulou, Dimitrios Alexopoulos
JAMA|March 15, 2012
Clopidogrel dosing based on genotypeDimitrios Alexopoulos, Ioanna Xanthopoulou
Journal of Cardiovascular Pharmacology and Therapeutics|July 12, 2018
Does Ticagrelor Improve Endothelial Function?Athanasios Moulias, Ioanna Xanthopoulou, Dimitrios Alexopoulos
Journal of the American College of Cardiology|December 4, 2014
Frequency of inappropriate and nonrecommended prasugrel prescription: great variationsDimitrios Alexopoulos, Ioanna Xanthopoulou, John Goudevenos
The American Journal of Cardiology|May 6, 2014
Effects of P2Y12 receptor inhibition in patients with ST-segment elevation myocardial infarctionDimitrios Alexopoulos, Ioanna Xanthopoulou, John Goudevenos
JACC. Cardiovascular Interventions|November 26, 2011
Percutaneous coronary interventions following coronary artery bypass graft in-hospital mortality and long-term follow-upGrigorios Tsigkas, Ioanna Xanthopoulou, Dimitrios Alexopoulos
Current Pharmaceutical Design|April 16, 2014
Pleiotropic effects of platelet P2Y12 receptor inhibitors: fact or fiction?Athanasios Moulias, Ioanna Xanthopoulou, Dimitrios Alexopoulos
Pageof 12